Stress Ages You Faster. Recovery Can Reverse It, Study Finds

Aging has long been treated as a one-way ratchet: biological damage accumulates, clocks tick forward, and nothing winds them back. A 2023 study published in Cell Metabolism by researchers at Harvard Medical School, Brigham and Women's Hospital, and Duke University now challenges that assumption directly. Across mouse models and three distinct human stress scenarios, biological age spiked sharply during periods of physiological stress and then returned to baseline once the stressor resolved.

Biological Age Spikes Then Reverses After Major Surgery, Pregnancy, and COVID-19

The research team, led by Jesse R. Poganik and Vadim N. Gladyshev, measured biological age using multiple independent epigenetic aging clocks: molecular tools that read chemical modifications on DNA to estimate how old the body's cells appear to be, regardless of the calendar date. In human cohorts, three scenarios triggered measurable biological age increases. Patients undergoing emergency surgery showed elevated biological age the morning after their procedure, with levels returning to pre-surgery baselines within four to seven days. Pregnant people had higher biological age at the time of delivery, a change that also reversed in the postpartum period. Older adults hospitalized with severe COVID-19 similarly showed elevated biological age that declined during recovery. Crucially, the immunosuppressive drug tocilizumab was associated with greater and faster biological age reversal in COVID-19 patients, suggesting that inflammation drives at least some of the transient aging signal.

These are not subtle statistical effects. The changes appeared consistently across epigenetic, transcriptomic, and metabolomic measurements, meaning the signal was visible at the level of DNA methylation, gene activity, and small-molecule chemistry simultaneously. As Gladyshev put it, "despite the widespread acknowledgment that biological age is at least somewhat malleable, the extent to which biological age undergoes reversible changes throughout life and the events that trigger such changes remain unknown" before this work.

Why Reversible Biological Aging Matters for Longevity Research

If biological age were simply a slow accumulation of irreversible damage, none of these reversals would be possible. The fact that they happen, and happen quickly, opens a fundamentally different way of thinking about aging. Each stressful episode could leave a small permanent residue even if most of the biological age increase disappears: a ratchet that mostly snaps back but not entirely. That residue, accumulated over decades, might explain why repeated major illnesses or surgeries tend to shorten healthspan in older adults.

The flip side is just as important. If biological age can drop, interventions designed to lower it become more plausible than a strictly damage-accumulation model would suggest. The speed of recovery observed here, days for surgery patients and weeks for COVID-19 survivors, implies that the body has active molecular programs for resetting age-related signals, not just passive damage-removal pathways. Recovery rate of biological age, the team argues, could serve as a practical readout for testing the efficacy of anti-aging therapies. Researchers tracking advances in metabolomics biomarker discovery have noted similar momentum toward using small-molecule profiles for early detection and treatment monitoring, which aligns with the multi-omics approach used here.

Heterochronic Parabiosis Confirmed the Pattern in Mice

The mouse experiments provided a mechanistic anchor for the human observations. The team used heterochronic parabiosis, a procedure in which a young mouse is surgically joined to an older mouse so the two animals share circulation. This is an established but extreme physiological stressor. Young mice in these pairs showed a measurable increase in biological age, consistent with exposure to the older animal's blood environment. After the animals were surgically separated and given time to recover, biological age in the young mice returned toward pre-procedure levels. Poganik noted that "reversibility of such changes, as we observed, has not yet been reported" before this study, making the finding genuinely novel even within the parabiosis literature.

The multi-level measurement strategy, spanning epigenetics, transcriptomics, and metabolomics, was central to the study's credibility. NMR and mass spectrometry techniques in metabolomics now allow researchers to profile hundreds of small molecules simultaneously in blood, and the team at the Broad Institute's metabolomics platform used that capability to track metabolomic aging signatures alongside the epigenetic clocks. Second-generation epigenetic clocks, which are calibrated against a broader range of aging phenotypes than earlier versions, proved more sensitive to these transient fluctuations than first-generation tools.

Open Questions About Long-Term Consequences and Individual Variation

The study raises as many questions as it answers. Not all pregnant individuals showed the same rate or extent of biological age recovery after delivery, suggesting that individual factors, possibly including genetics, baseline health, or the severity of the physiological stress, shape how completely the reset occurs. The research also could not definitively distinguish between short-term biological age fluctuations and long-term aging trajectories: a person might recover to apparent baseline after surgery without recovering along dimensions the current clocks cannot yet detect. As James White of Duke noted, "a key area for further investigation is understanding how transient elevations in biological age or successful recovery from such increases may contribute to accelerated aging over the life course."

The reliance on DNA methylation clocks as the primary measurement tool is also a practical limitation, not a flaw so much as a constraint of what technology currently allows. Emerging approaches in metabolomics-based biomarker research continue to expand the toolkit, but epigenetic clocks remain the most statistically powerful and reproducible option for longitudinal aging studies in humans at scale.

Stress-Induced Biological Aging as a Measurable Drug Target

The most immediate practical implication of this work is quantitative: the elevation of biological age by stress is now a measurable, trackable variable, and the rate at which it reverses could function as a clinical endpoint. That framing could change how gerotherapeutics, drugs or interventions targeting the aging process, are tested. Rather than waiting years for mortality or disease outcomes, researchers could potentially use rapid biological age recovery as a proxy signal in shorter trials.

The observation that tocilizumab, which blocks the inflammatory cytokine receptor IL-6, appeared to accelerate biological age reversal in COVID-19 patients also points toward inflammation as a key driver of stress-induced aging rather than just a passenger. That thread connects this work to a much broader literature on inflammaging, the chronic low-grade inflammation associated with advancing age. If short, acute inflammatory spikes can push biological age upward in measurable ways, then controlling those spikes more effectively during critical illness or surgery could have compounding benefits over a lifetime. The study was supported in part by NIA grant R21AG065943, and its implications extend well beyond any single stressor or clinical context.